METABOLIC CONTROL AND PREVENTION OF NEPHROPATHY BY 2-TETRADECYLGLYCIDATE IN THE DIABETIC MOUSE (DB-DB)

被引：29

作者：

LEE, SM

TUTWILER, G

BRESSLER, R

KIRCHER, CH

机构：

[1] UNIV ARIZONA, DEPT MED, TUCSON, AZ 85721 USA

[2] MCNEIL PHARMACEUT, Spring House, PA USA

来源：

DIABETES | 1982年 / 31卷 / 01期

关键词：

D O I：

10.2337/diabetes.31.1.12

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：12 / 18

页数：7

相关论文

共 29 条

[21] AN ANALYSIS OF LIPOLYSIS IN-VITRO OF OBESE-HYPERGLYCAEMIC AND DIABETIC MICE
STEINMET.J
LOWRY, L
YEN, TTT
[J]. DIABETOLOGIA, 1969, 5 (06) : 373 - &
[22] TUMAN RW, 1981, DIABETES S1, V30, pA133
[23] INHIBITION OF MITOCHONDRIAL CARNITINE PALMITOYL TRANSFERASE BY 2-TETRADECYLGLYCIDIC ACID (MCN-3802)
TUTWILER, GF
RYZLAK, MT
[J]. LIFE SCIENCES, 1980, 26 (05) : 393 - 397
[24] PHARMACOLOGIC PROFILE OF METHYL 2-TETRADECYLGLYCIDATE (MCN-3716) - ORALLY EFFECTIVE HYPOGLYCEMIC AGENT
TUTWILER, GF
KIRSCH, T
MOHRBACHER, RJ
HO, W
[J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 1978, 27 (10): : 1539 - 1556
[25] METHYL 2-TETRADECYLGLYCIDATE, AN ORALLY EFFECTIVE HYPOGLYCEMIC AGENT THAT INHIBITS LONG-CHAIN FATTY-ACID OXIDATION SELECTIVELY
TUTWILER, GF
MOHRBACHER, R
HO, W
[J]. DIABETES, 1979, 28 (03) : 242 - 248
[26] PHARMACOLOGIC PROFILE OF MCN-3495 [N-(1-METHYL-2-PYRROLIDINYLIDENE)-N'-PHENYL-1-PYRROLIDINECARBOXIMIDAMIDE], A NEW, ORALLY EFFECTIVE HYPOGLYCEMIC AGENT
TUTWILER, GF
KIRSCH, T
BRIDI, G
[J]. DIABETES, 1978, 27 (08) : 856 - 867
[27] TUTWILER GF, 1979, J BIOL CHEM, V254, P2935
[28] TUTWILER GF, 1981, METHOD ENZYMOL, V73, P533
[29] TUTWILER GF, 1981, FED P